Amphastar PharmaceuticalsAMPH

那斯達克 · USD
21.66
+0.14
(+0.65%)
盤中 08/25 10:51 (UTC+8)
08/25 10:51 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 1.72
  • 1.82
  • 1.91
  • 1.87
  • 1.71
  • 1.74
  • 1.92
  • 1.83
  • 1.71
  • 1.84
icon
  • -3.52
  • 6.14
  • 4.84
  • -2.45
  • -8.58
  • 2.28
  • 9.99
  • -4.55
  • -6.52
  • 7.44
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
183,903
171,171
183,105
191,840
174,414
170,528
186,523
191,214
182,394
171,836
營業成本
90,433100,84997,43593,19487,92485,27799,87589,27387,22881,736
營業毛利
93,470
70,322
85,670
98,646
86,490
85,251
86,648
101,941
95,166
90,100
營業費用
53,74156,69250,06473,32644,30647,958-44,89339,94942,090
研發費用
22,16426,73723,31422,35420,08020,09618,14221,07717,65217,043
推銷及管理費用
31,57729,95526,75050,97224,22627,86223,36223,81622,29725,047
非經常性項目費用
----------
其他營業費用
----------
營業利益
39,729
13,630
35,606
25,320
42,184
37,293
45,144
57,048
55,217
48,010
其他收入及費用
5,4742,9752,9382,4773,432-1455,243-2,6673,6358,477
利息費用
6,6596,5536,6306,2846,2816,2866,4256,6988,6098,611
稅前純益
38,544
10,052
31,914
21,513
39,335
30,862
43,962
47,683
50,243
47,876
所得稅
8,1963,6327,4854,1638,3055,5775,9987,25412,2944,126
稅後純益
30,348
6,420
24,429
17,350
31,030
25,285
37,964
40,429
37,949
43,177
基本每股稅後盈餘(元)
0.690.140.530.380.660.530.790.830.770.90
稀釋每股稅後盈餘(元)
0.670.140.510.370.640.510.740.780.730.81
基本平均股數(千股)
43644.0045322.0045907.0046474.0046949.0047641.0047975.0048621.0048907.0048212.00
稀釋平均股數(千股)
44225.0046458.0047164.0047677.0048128.0049890.0051310.0051862.0052046.0053013.00
還原基本每股稅後盈餘(元)
0.690.140.530.380.660.530.790.830.770.90
還原稀釋每股稅後盈餘(元)
0.670.140.510.370.640.510.740.780.730.81
還原基本平均股數(千股)
43,64445,32245,90746,47446,94947,64147,97548,62148,90748,212
還原稀釋平均股數(千股)
44,22546,45847,16447,67748,12849,89051,31051,86252,04653,013
EBITDA(千元)
62,53833,85855,39744,45062,69753,11765,77569,55875,43372,005

大家都在看

HOT